Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arena Pharmaceuticals Inc (NASDAQ:ARNA)

1.36
Delayed Data
As of 4:00pm ET
 -0.02 / -1.45%
Today’s Change
1.13
Today|||52-Week Range
2.16
-4.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues81.4M37.0M38.3M124.0M
 
 
 
 
 
Cost of Goods Sold2.1M3.2M3.1M6.0M
 
 
 
 
 
Depreciation And Amortization8.2M9.2M10.0M9.4M
 
 
 
 
 
 
Operating ExpensesGross Income71.1M24.6M25.2M108.6M
 
 
 
 
 
General Expenses94.0M129.9M124.4M97.7M
 
 
 
 
 
Research And Development66.5M100.3M88.4M66.4M
 
 
 
 
 
Total Operating Expenses104.3M142.2M137.6M113.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.9M-105.3M-99.2M11.0M
 
 
 
 
 
Extraordinary Credit10.2M4.4M474.0K0.00
 
 
 
 
Extraordinary Charge0.000.00-4.0M-28.1M
 
 
 
Interest Expense On Debt7.1M6.9M6.8M6.5M
 
 
 
 
 
Other Expenses352.0K47.2M1.4M472.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.4M-60.5M-108.0M-22.9M
 
 
 
 
 
Minority Interest0.000.000.00-380.0K
 
 
Net Income-19.4M-60.5M-108.0M-22.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS218.1M219.7M240.7M243.1M
 
 
 
 
 
Shares To Calculate EPS Diluted218.1M219.7M240.7M243.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09-$0.28-$0.45-$0.09
 
 
 
 
 
EPS Diluted-$0.09-$0.28-$0.45-$0.09